⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 13, 2022Molecular Cancer TherapeuticsOpen Access

Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation

View Full Paper

Ask AI

Bookmark

Share

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2022 study studied this question.

synapsesocial.com/papers/6a9e623d62cda43c8ec3c885 https://doi.org/10.1158/1535-7163.mct-21-0103

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL2010 · 75 citations
2Adverse effects of androgen‐deprivation therapy in prostate cancer and their management2014 · 135 citations
3The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer2016 · 434 citations
4REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer2013 · 154 citations